143 related articles for article (PubMed ID: 26183549)
1. Tumor Diameter is an Easy and Useful Predictor of Recurrence in Stage II Colorectal Cancer.
Maeda C; Hidaka E; Mori Y; Mukai S; Miyachi H; Sawada N; Ishida F; Kudo SE
Dig Surg; 2015; 32(5):338-43. PubMed ID: 26183549
[TBL] [Abstract][Full Text] [Related]
2. Surgical outcomes for colon and rectal cancer over a decade: results from a consecutive monocentric experience in 902 unselected patients.
Andreoni B; Chiappa A; Bertani E; Bellomi M; Orecchia R; Zampino M; Fazio N; Venturino M; Orsi F; Sonzogni A; Pace U; Monfardini L
World J Surg Oncol; 2007 Jul; 5():73. PubMed ID: 17610720
[TBL] [Abstract][Full Text] [Related]
3. Elevation of preoperative s-CEA concentration in stage IIA colorectal cancer can also be a high risk factor for stage II patients.
Kim CW; Yoon YS; Park IJ; Lim SB; Yu CS; Kim JC
Ann Surg Oncol; 2013 Sep; 20(9):2914-20. PubMed ID: 23760586
[TBL] [Abstract][Full Text] [Related]
4. The Number of Risk Factors Determines the Outcome Of Stage II Colorectal Cancer Patients.
Lin HH; Yang HL; Lin JK; Lin CC; Wang HS; Yang SH; Jiang JK; Lan YT; Lin TC; Chen WS; Liang WY; Chang SC
Hepatogastroenterology; 2014 Jun; 61(132):1024-7. PubMed ID: 26158160
[TBL] [Abstract][Full Text] [Related]
5. Prognostic significance of multiple molecular markers for patients with stage II colorectal cancer undergoing curative resection.
Uen YH; Lin SR; Wu DC; Su YC; Wu JY; Cheng TL; Chi CW; Wang JY
Ann Surg; 2007 Dec; 246(6):1040-6. PubMed ID: 18043108
[TBL] [Abstract][Full Text] [Related]
6. Adjuvant chemotherapy increase survival and decrease recurrence in stage IIA colon cancer.
Yun HR; Kim HC; Yun SH; Lee WY
Hepatogastroenterology; 2012; 59(120):2466-71. PubMed ID: 23169179
[TBL] [Abstract][Full Text] [Related]
7. Prognostic significance of preoperative bowel obstruction in stage III colorectal cancer.
Katoh H; Yamashita K; Wang G; Sato T; Nakamura T; Watanabe M
Ann Surg Oncol; 2011 Sep; 18(9):2432-41. PubMed ID: 21369738
[TBL] [Abstract][Full Text] [Related]
8. Adjuvant chemotherapy for the perineural invasion of colorectal cancer.
Suzuki T; Suwa K; Ogawa M; Eto K; Kawahara H; Fujita T; Ikegami M; Yanaga K
J Surg Res; 2015 Nov; 199(1):84-9. PubMed ID: 25935467
[TBL] [Abstract][Full Text] [Related]
9. Characteristics and risk factors for colorectal cancer recurrence.
Dogan L; Karaman N; Yilmaz KB; Ozaslan C; Atalay C; Altinok M
J BUON; 2010; 15(1):61-7. PubMed ID: 20414929
[TBL] [Abstract][Full Text] [Related]
10. Is perineural invasion (PN) a determinant of disease free survival in early stage colorectal cancer?
Ozturk MA; Dane F; Karagoz S; Tural D; Selcukbiricik F; Demirelli F; Buyukunal E; Ozguroglu M; Turna H; Erdamar S; Celikel CA; Bozkurtlar EB; Yumuk PF; Mandel NM; Turhal NS; Serdengecti S
Hepatogastroenterology; 2015; 62(137):59-64. PubMed ID: 25911868
[TBL] [Abstract][Full Text] [Related]
11. Influence of family history on survival in patients with colon and rectal cancer.
Lee SD; Kim BC; Han KS; Hong CW; Sohn DK; Park JW; Park SC; Kim SY; Baek JY; Chang HJ; Kim DY; Oh JH
J Dig Dis; 2014 Mar; 15(3):108-15. PubMed ID: 24304621
[TBL] [Abstract][Full Text] [Related]
12. Predictive factors of early relapse in UICC stage I-III colorectal cancer patients after curative resection.
Tsai HL; Chu KS; Huang YH; Su YC; Wu JY; Kuo CH; Chen CW; Wang JY
J Surg Oncol; 2009 Dec; 100(8):736-43. PubMed ID: 19757443
[TBL] [Abstract][Full Text] [Related]
13. [Analysis of prognostic factors after radical resection in 628 patients with stage II or III colon cancer].
Qin Q; Yang L; Zhou AP; Sun YK; Song Y; DU F; Wang JW
Zhonghua Zhong Liu Za Zhi; 2013 Mar; 35(3):212-6. PubMed ID: 23880003
[TBL] [Abstract][Full Text] [Related]
14. Risk factors for recurrence in stage II/III colorectal cancer patients treated with curative surgery: The impact of postoperative tumor markers and an infiltrative growth pattern.
Tokodai K; Narimatsu H; Nishida A; Takaya K; Hara Y; Kawagishi N; Hashizume E; Ohuchi N
J Surg Oncol; 2016 Sep; 114(3):368-74. PubMed ID: 27264681
[TBL] [Abstract][Full Text] [Related]
15. Tumor deposit is a poor prognostic indicator for patients who have stage II and III colorectal cancer with fewer than 4 lymph node metastases but not for those with 4 or more.
Nagayoshi K; Ueki T; Nishioka Y; Manabe T; Mizuuchi Y; Hirahashi M; Oda Y; Tanaka M
Dis Colon Rectum; 2014 Apr; 57(4):467-74. PubMed ID: 24608303
[TBL] [Abstract][Full Text] [Related]
16. Prognostic value of perineural invasion in patients with stage II colorectal cancer.
Huh JW; Kim HR; Kim YJ
Ann Surg Oncol; 2010 Aug; 17(8):2066-72. PubMed ID: 20182809
[TBL] [Abstract][Full Text] [Related]
17. Evaluation of the efficacy of adjuvant chemotherapy in patients with high-risk stage II colon cancer.
Cakar B; Varol U; Junushova B; Muslu U; Gursoy Oner P; Gokhan Surmeli Z; Cirak Y; Karaca B; Sezgin C; Karabulut B; Uslu R
J BUON; 2013; 18(2):372-6. PubMed ID: 23818348
[TBL] [Abstract][Full Text] [Related]
18. A novel data-driven prognostic model for staging of colorectal cancer.
Manilich EA; Kiran RP; Radivoyevitch T; Lavery I; Fazio VW; Remzi FH
J Am Coll Surg; 2011 Nov; 213(5):579-588, 588.e1-2. PubMed ID: 21925905
[TBL] [Abstract][Full Text] [Related]
19. Impact of C-reactive protein on prognosis of patients with colorectal carcinoma.
Takasu C; Shimada M; Kurita N; Iwata T; Nishioka M; Morimoto S; Yoshikawa K; Miyatani T; Kashihara H; Utsunomiya T
Hepatogastroenterology; 2013 May; 60(123):507-11. PubMed ID: 23635436
[TBL] [Abstract][Full Text] [Related]
20. Prognostic significance of smoking in addition to established risk factors in patients with Dukes B and C colorectal cancer: a retrospective analysis.
Diamantis N; Xynos ID; Amptulah S; Karadima M; Skopelitis H; Tsavaris N
J BUON; 2013; 18(1):105-15. PubMed ID: 23613395
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
